Testing effectiveness (Phase 2)Looking for participantsNCT06623110
What this trial is testing
Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
Who this might be right for
High-Risk Oral Precancerous Disease
Glenn J. Hanna 25